Hikma share price: AGM trading update confirms upbeat guidance

on May 14, 2015
Updated: Oct 21, 2019

Hikma Pharmaceuticals Plc (LON:HIK) issued a trading update ahead of its annual general meeting today. Following are the highlights of the company’s statement.

Are you looking for signals & alerts from pro-traders? Sign-up to Invezz Signals™ for FREE. Takes 2 mins.

**Highlights from Hikma’s trading update:**
Hikma has made a good start to the year and we are very pleased to reiterate our guidance for 2015 for the Group overall and for each of our business segments.

We continue to expect full year Group revenue growth of around 6% in constant currency, following an extremely strong year in 2014, in which profit attributable to shareholders increased by 30%. On a reported basis, we expect full year Group revenue growth of around 2%, reflecting foreign exchange rate movements in the year to date. For the first half, we expect Group revenue in constant currency to be broadly in line with the same period last year.
Said Darwazah, Chairman and Chief Executive Officer of Hikma said:
“Hikma has made a good start to the year. We have performed well in each of our businesses following an extremely strong 2014, and we are pleased to be reiterating our 2015 guidance for the Group overall and for each of our business segments.

Over the longer-term, we are confident in our ability to continue to drive strong growth across the Hikma Group. By strengthening our operations in the MENA region, enhancing and expanding our global Injectables business and developing our non-injectable Generics portfolio in the US, we are building an extremely robust set of businesses that are uniquely positioned to capture a range of attractive future growth opportunities. ”

We will announce our interim results for the six months to 30 June 2015 on 19 August 2015.
As of 07:12 BST, Thursday, 14 May, Hikma Pharmaceuticals Plc share price is 2,030.00p.


Want easy-to-follow crypto, forex & stock trading signals? Make trading simple by copying our team of pro-traders. Consistent results. Sign-up today at Invezz Signals.

Learn more
Health & pharma Manufacturing Stock Market